Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.550
+0.040 (2.65%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Cellectis Market Cap

Cellectis has a market cap or net worth of $113.06 million as of April 25, 2025. Its market cap has decreased by -27.11% in one year.

Market Cap
113.06M
Enterprise Value
52.71M
1-Year Change
-27.11%
Ranking
Category
Stock Price
$1.55

Market Cap Chart

Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $113.06M, a decrease of -91.59%. That is a compound annual growth rate of -21.75%.

History

DateMarket Cap% Change
Apr 25, 202542.80M-76.25%
Dec 31, 2024180.20M5.26%
Dec 29, 2023171.20M78.89%
Dec 30, 202295.70M-74.09%
Dec 31, 2021369.30M-67.88%
Dec 31, 20201.15B58.27%
Dec 31, 2019726.40M2.87%
Dec 31, 2018706.10M-31.45%
Dec 29, 20171.03B72.73%
Dec 30, 2016596.30M-43.80%
Dec 31, 20151.06B-21.04%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 794.31B
UnitedHealth Group 381.06B
Johnson & Johnson 371.93B
AbbVie 329.14B
Novo Nordisk 272.76B
Abbott Laboratories 223.47B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings